SCHEMBL2179487

SCHEMBL2179487

CC(C)C(C(=O)O)N1Cc2ccc(-c3ccc(NC(=S)Nc4cccc(C#N)c4)cc3)cc2C1=O

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
KDR P35968 1/20 0.44
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
SDCBP O00560 3/20 0.39
SDC2 P34741 3/20 0.39
NAMPT P43490 1/20 0.39
IDO1 P14902 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MCHR1 Q99705 2/20 0.39
ADAMTS4 O75173 1/20 0.38
VHL P40337 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179482 1.00 ALDH1A1 (0.47) ALDH1A1MAPTKDRLMNATP53
SCHEMBL2179408 0.93 KDR (0.52) ALDH1A1MAPTKDRLMNATP53
SCHEMBL2177431 0.93 KDR (0.52) ALDH1A1MAPTKDRLMNATP53
SCHEMBL2179200 0.92 LMNA (0.41) LMNATP53SDCBPSDC2NAMPT
SCHEMBL2178811 0.92 LMNA (0.41) LMNATP53SDCBPSDC2NAMPT
SCHEMBL2179260 0.87 PPIA (0.46) MAPTKDRLMNATP53SDCBP
SCHEMBL2179028 0.87 SDCBP (0.45) ALDH1A1KDRLMNATP53SDCBP
SCHEMBL2181156 0.87 PPIA (0.46) MAPTKDRLMNATP53SDCBP
SCHEMBL2178453 0.86 MEN1 (0.47) ALDH1A1MAPTKDRLMNATP53
SCHEMBL2178135 0.86 MEN1 (0.47) ALDH1A1MAPTKDRLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748426-B2 Inhibitors of diacylglycerol acyl transferase Piramal Enterprises Limited (IN) 2014-06-10 US claimed
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Enterprises Limited (IN) 2012-11-15 US claimed
EP-2519500-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Healthcare Ltd. (IN) 2012-11-07 EP claimed
WO-2011080718-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-07-07 WO claimed
US-8748426-B2 Inhibitors of diacylglycerol acyl transferase Piramal Enterprises Limited (IN) 2014-06-10 US disclosed
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Enterprises Limited (IN) 2012-11-15 US disclosed
EP-2519500-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Healthcare Ltd. (IN) 2012-11-07 EP disclosed
WO-2011080718-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE DGAT1, DGAT2, LCAT ALDH1A1 715/4885MAPT 116/4885KDR 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.